The Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT Trial
Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training (ACT) in MCI
1 other identifier
interventional
146
1 country
4
Brief Summary
This multi-site clinical trial occurs at the University of Minnesota and University of Rochester. It tests the efficacy and additive/synergistic effects of an ACT intervention on cognition and relevant mechanisms (aerobic fitness, Alzheimer's disease \[AD\] signature cortical thickness, and default mode network \[DMN\]) in older adults with amnestic MCI (aMCI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2017
CompletedFirst Posted
Study publicly available on registry
October 18, 2017
CompletedStudy Start
First participant enrolled
July 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 17, 2024
CompletedApril 25, 2025
August 1, 2024
6 years
October 6, 2017
April 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Executive function
EXAMINER
Change from baseline to 3, 6, 12, and 18 months
Episodic memory
RAVLT and BVMTR
Change from baseline to 3, 6, 12, and 18 months
AD-signature cortical thickness
Magnetic Resonance Imaging (MRI)
Change from baseline to 6, 12, and 18 months
Functional connectivity in DMN
Functional MRI for Default Mode Network
Change from baseline to 6, 12, and 18 months
Aerobic fitness
VO2peak from symptom-limited peak cycle-ergometer test, and 10-m Incremental Shuttle Walk Test
Change from baseline to 3, 6, 12, and 18 months
Conversion to Alzheimer's disease
Clinical adjudication of Alzheimer's disease dementia
Change from baseline to 6, 12, and 18 months
Study Arms (4)
Cycling Only
ACTIVE COMPARATORModerate-intensity cycling, 3 times a week for 6 months, supervised by an exercise specialist
Cognitive Training Only
ACTIVE COMPARATORComputerized cognitive training, 3 times a week for 6 months, supervised by a specialist
ACT
EXPERIMENTALModerate-intensity cycling followed by computerized cognitive training, 3 times a week for 6 months, supervised by a specialist
Stretching and Mental Stimulation Activities
SHAM COMPARATORStretching and mental stimulation activities, 3 times a week for 6 months, supervised by a specialist
Interventions
ACT stands for combined aerobic exercise and cognitive training.
Stretching exercises and mental stimulating activities on a computer
Eligibility Criteria
You may qualify if:
- A clinical diagnosis of MCI
- Community-dwelling
- Age 65 years and older
- English-speaking
- Adequate visual acuity
- Verified exercise safety by medical provider
- Stable on drugs affecting cognitive and psychological status
- Verified MRI safety
- Capacity to consent
You may not qualify if:
- Geriatric Depression Scale \< 5
- Resting heart rate (HR) ≤50 due to arrhythmia or ≥100 beats/min
- Neurological (e.g., dementia, head trauma), psychiatric (e.g., bipolar, schizophrenia, or depression), or substance dependency (alcohol or chemical dependency) in the past 5 years that are the main contributor to MCI
- Contraindications to exercise, e.g. unstable angina, recent surgery
- New symptoms or diseases that have not been evaluated by a health care provider
- Current enrollment in another intervention study related to cognitive improvement (reduce confounding effects on outcomes)
- Abnormal MRI findings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arizona State Universitylead
- University of Rochestercollaborator
- Mayo Cliniccollaborator
- University of St Thomascollaborator
- University of Minnesotacollaborator
Study Sites (4)
Arizona State University
Phoenix, Arizona, 85004, United States
Stanford University
Stanford, California, 94305, United States
University of Minnesota
Minneapolis, Minnesota, 55455, United States
University of Rochester
Rochester, New York, 14642, United States
Related Publications (4)
Derboghossian G, Pituch K, Anthony M, Salisbury D, Lin FV, Yu F. Relationships among cardiorespiratory fitness, brain age, and neurodegeneration in older adults with amnestic mild cognitive impairment. J Alzheimers Dis. 2025 Jun;105(3):945-954. doi: 10.1177/13872877251333613. Epub 2025 Apr 22.
PMID: 40262108DERIVEDSalisbury DL, Lin FV, Yu F. Testing the iMplementation Framework fOr behavioral and LIfestyLe interventions in AlZheimer's DiseasE (MOBILIZE) via the ACT randomized controlled trial. Sci Rep. 2025 Feb 13;15(1):5341. doi: 10.1038/s41598-025-88890-9.
PMID: 39948366DERIVEDLi D, Mielke MM, Bell WR, Reilly C, Zhang L, Lin FV, Yu F. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial). Trials. 2020 Jan 6;21(1):19. doi: 10.1186/s13063-019-3798-1.
PMID: 31907024DERIVEDYu F, Lin FV, Salisbury DL, Shah KN, Chow L, Vock D, Nelson NW, Porsteinsson AP, Jack C Jr. Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial. Trials. 2018 Dec 22;19(1):700. doi: 10.1186/s13063-018-3054-0.
PMID: 30577848DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fang Yu, PhD
Arizona State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2017
First Posted
October 18, 2017
Study Start
July 5, 2018
Primary Completion
July 17, 2024
Study Completion
July 17, 2024
Last Updated
April 25, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share